{"gene":"SRR","run_date":"2026-06-10T07:46:41","timeline":{"discoveries":[{"year":2011,"finding":"SRR (serine racemase) is the major enzyme responsible for D-serine production in the mouse forebrain (frontal cortex, hippocampus, striatum), as demonstrated by significantly reduced D-serine levels in Srr-KO mice in these regions; cerebellar D-serine was unaffected, suggesting alternative biosynthetic pathways exist there. In vivo microdialysis confirmed reduced extracellular hippocampal D-serine in Srr-KO mice.","method":"Srr knockout mice, HPLC amino acid quantification across brain regions and peripheral organs, in vivo microdialysis","journal":"Neurochemistry international","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined biochemical phenotype across multiple brain regions and peripheral organs, replicated with two orthogonal methods (tissue quantification and in vivo microdialysis)","pmids":["21906644"],"is_preprint":false},{"year":2013,"finding":"SRR knockout mice show significantly reduced D-aspartic acid levels in forebrain regions (frontal cortex, hippocampus, striatum) but not cerebellum, suggesting SRR and/or D-serine is involved in D-aspartic acid production in the forebrain. D-aspartate oxidase (DDO) activity was unchanged in Srr-KO forebrains, ruling out altered catabolism as an explanation.","method":"Srr knockout mice, HPLC amino acid quantification, DDO enzymatic activity assay","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean KO with defined biochemical phenotype, single lab, indirect mechanism (SRR→D-serine→D-aspartate pathway not fully resolved)","pmids":["23439386"],"is_preprint":false},{"year":2010,"finding":"In C6 glioma cells expressing SRR but lacking DAO activity, SRR overexpression increased D-serine and pyruvate levels and decreased ASCT2 mRNA and [(3)H]D-serine uptake, demonstrating SRR operates in both racemase mode (producing D-serine) and alpha,beta-eliminase mode (converting D-serine to pyruvate). ASCT2-mediated transport contributes to D-serine homeostasis in DAO-deficient cells.","method":"SRR overexpression and RNAi knockdown in C6 glioma cells, D-serine/pyruvate measurement, [(3)H]D-serine uptake assay, immunoblot","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function and loss-of-function with multiple biochemical readouts, single lab","pmids":["20091774"],"is_preprint":false},{"year":2005,"finding":"Human brain SRR transcripts consist of four mRNA isoforms with one major species, arising from alternative use of various 5' end exons, as determined by complete cDNA and genomic structure analysis. SRR encodes an enzyme catalyzing formation of D-serine from L-serine.","method":"cDNA cloning, genomic structure determination, mutation screening","journal":"Biological psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cDNA/genomic structural characterization with identification of isoforms, single lab","pmids":["15953485"],"is_preprint":false},{"year":2024,"finding":"Inhibition of SRR by oral gavage of L-aspartic acid β-hydroxamate (L-ABH), a competitive inhibitor of SRR, mitigated photoreceptor dysfunction, loss of retinal ganglion cells, and loss of retinal endothelial cells and pericytes in db/db diabetic mice. Intravitreal L-ABH also mitigated glutamate-induced neurotoxicity in the retina. Systemic L-ABH maintained euglycemia and improved glucose tolerance in diabetic and diet-induced obesity mice, establishing a neuroprotective and metabolic role for SRR inhibition in diabetic retinopathy.","method":"In vivo pharmacological inhibition (competitive inhibitor L-ABH) in db/db mice, intravitreal injection, electroretinography, histological cell counts, glucose tolerance tests","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological loss-of-function with multiple cellular and metabolic readouts in disease model, single lab, preprint not peer-reviewed","pmids":[],"is_preprint":true},{"year":1992,"finding":"The ILV1 gene of S. cerevisiae (encoding threonine dehydratase, the yeast ortholog of SRR/ILV1) requires a REB1-binding site (ILV1BAS) for GCN4-independent basal-level transcription. Gel retardation assays showed REB1 specifically binds this element. An ABF1-binding site can functionally substitute for the REB1 site, suggesting related transcriptional activation functions for these proteins at ILV1.","method":"ILV1 promoter deletion analysis, gel retardation assay (EMSA), reporter gene assays, point mutation analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro binding assay (EMSA) plus in vivo promoter deletion and point mutation analysis, single lab; pertains to yeast ILV1 ortholog regulation","pmids":["1448083"],"is_preprint":false},{"year":1998,"finding":"Dat1p (datin), the yeast poly(dA:dT)-binding protein, specifically binds the ILV1 poly(dA:dT) promoter element in vitro and functions as a trans-activating factor for ILV1 expression. The REB1-binding site and the poly(dA:dT) element act synergistically in a distance-dependent manner to control ILV1 basal-level expression, and this synergy depends on the DAT1 structural gene.","method":"In vitro binding assay (gel retardation/EMSA), in vivo promoter deletion analysis, DAT1 gene deletion epistasis, reporter gene assays","journal":"Molecular & general genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding plus in vivo genetic epistasis and reporter assays, single lab; pertains to yeast ILV1 ortholog","pmids":["9613577"],"is_preprint":false},{"year":2001,"finding":"Chromatin analysis of the yeast ILV1 locus revealed highly positioned nucleosomes with a hypersensitive site in the promoter region containing all known regulatory elements. However, replacing or deleting the poly(dA:dT) elements or the REB1-binding site drastically reduced ILV1 basal transcription without detectably altering chromatin structure at the promoter, demonstrating the chromatin organization is independent of these regulatory elements and is most likely dictated directly by DNA sequence.","method":"Chromatin structure analysis (nucleosome mapping), promoter deletion/substitution analysis, in vivo transcription assays","journal":"Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chromatin structure mapping combined with mutational analysis; single lab; yeast ILV1 ortholog","pmids":["11706001"],"is_preprint":false},{"year":1997,"finding":"Phenotypic suppression of yeast ilv1 (threonine dehydratase deficiency) can occur via inducer-mediated or constitutive transcriptional activation of CHA1, a second serine/threonine deaminase. Genetic analysis identified SIL4 (allelic to HOM3) as a dominant suppressor that increases the threonine pool 15-20-fold to induce CHA1 transcription; SIL3 and sil2 (both alleles of CHA4) constitutively activate CHA1 transcription as dominant and recessive suppressors, respectively.","method":"Suppressor screen, genetic epistasis analysis, CHA1-lacZ reporter assay, metabolite pool measurement","journal":"Molecular & general genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic suppressor analysis with epistasis and reporter gene confirmation, single lab; yeast ILV1 ortholog","pmids":["9323359"],"is_preprint":false},{"year":1987,"finding":"The S. cerevisiae ILV1 gene product (threonine dehydratase, EC 4.2.1.16) functionally complements a threonine dehydratase-deficient Nicotiana plumbaginifolia plant mutant after Agrobacterium-mediated gene transfer, confirming that ILV1 encodes a functional threonine dehydratase enzyme conserved in activity across kingdoms.","method":"Heterologous complementation via Agrobacterium-mediated gene transfer, enzymatic activity assay for threonine dehydratase in transformed plant lines, selection on isoleucine-free medium","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional complementation assay combined with direct enzymatic activity measurement, confirming catalytic function of ILV1 gene product","pmids":["3302681"],"is_preprint":false}],"current_model":"SRR (serine racemase) is a pyridoxal-5'-phosphate-dependent enzyme that catalyzes the racemization of L-serine to D-serine (and can also operate in alpha,beta-eliminase mode producing pyruvate), making it the primary source of D-serine — an endogenous NMDA receptor co-agonist — in the mammalian forebrain; SRR also appears to influence D-aspartic acid levels in the forebrain and plays roles in retinal neuroprotection and glucose homeostasis, while its yeast ortholog (ILV1/threonine dehydratase) is regulated at the transcriptional level by REB1 and Dat1p binding to the promoter in a synergistic, distance-dependent manner."},"narrative":{"mechanistic_narrative":"SRR (serine racemase) is the principal enzyme generating D-serine in the mammalian forebrain, where D-serine acts as an endogenous co-agonist of the NMDA receptor; genetic ablation of Srr in mice selectively depletes D-serine in frontal cortex, hippocampus, and striatum while sparing the cerebellum, which retains alternative biosynthetic routes [PMID:21906644]. Biochemically the enzyme is bifunctional: in cells expressing SRR it both produces D-serine in racemase mode and converts D-serine to pyruvate in an alpha,beta-eliminase mode, with extracellular D-serine homeostasis further shaped by ASCT2-mediated transport [PMID:20091774]. SRR activity also influences forebrain D-aspartic acid levels through a mechanism downstream of D-serine rather than altered D-aspartate catabolism [PMID:23439386]. Pharmacological inhibition of SRR with the competitive inhibitor L-aspartic acid β-hydroxamate is neuroprotective in the diabetic retina and improves glucose tolerance, implicating the enzyme in retinal disease and metabolic homeostasis. The gene is expressed as multiple mRNA isoforms arising from alternative 5' exon usage [PMID:15953485]. The yeast ortholog ILV1 encodes a functional threonine dehydratase whose conserved catalytic activity has been demonstrated by cross-kingdom complementation [PMID:3302681], and whose basal transcription is governed by REB1- and Dat1p-binding promoter elements acting synergistically in a distance-dependent manner [PMID:1448083, PMID:9613577].","teleology":[{"year":1987,"claim":"Established that the ancestral/ortholog gene product is a catalytically active enzyme, anchoring the protein's biochemical identity before its mammalian racemase role was known.","evidence":"Agrobacterium-mediated transfer of yeast ILV1 complementing a threonine dehydratase-deficient plant mutant with direct enzyme activity measurement","pmids":["3302681"],"confidence":"High","gaps":["Does not address racemase activity or D-serine production","Yeast/plant system, not mammalian SRR"]},{"year":1992,"claim":"Defined how basal transcription of the yeast ortholog is controlled, identifying a REB1-binding promoter element required for GCN4-independent expression.","evidence":"ILV1 promoter deletion/point-mutation analysis plus EMSA showing specific REB1 binding, with ABF1 site substitution","pmids":["1448083"],"confidence":"Medium","gaps":["Yeast-specific transcriptional regulation; mammalian SRR promoter not addressed","Mechanism of REB1/ABF1 functional equivalence unresolved"]},{"year":1997,"claim":"Mapped genetic suppressors that bypass loss of the yeast deaminase, illuminating metabolic compensation through CHA1 activation.","evidence":"Suppressor screen, epistasis, CHA1-lacZ reporter and metabolite pool measurement in yeast ilv1 mutants","pmids":["9323359"],"confidence":"Medium","gaps":["Pertains to yeast amino acid metabolism, not mammalian D-serine function"]},{"year":1998,"claim":"Showed that a second promoter element bound by Dat1p cooperates with the REB1 site to drive basal expression, defining a synergistic distance-dependent regulatory architecture for the ortholog.","evidence":"EMSA binding, promoter deletion, DAT1 deletion epistasis and reporter assays in yeast","pmids":["9613577"],"confidence":"Medium","gaps":["Yeast-specific; relevance to mammalian SRR regulation unknown"]},{"year":2001,"claim":"Determined that the ordered chromatin structure at the ortholog promoter is sequence-dictated and independent of the regulatory elements driving transcription.","evidence":"Nucleosome mapping with promoter deletion/substitution and in vivo transcription assays in yeast","pmids":["11706001"],"confidence":"Medium","gaps":["Yeast-specific chromatin context","Does not connect to mammalian enzyme function"]},{"year":2005,"claim":"Characterized the human gene structure, revealing four mRNA isoforms from alternative 5' exon usage in human brain.","evidence":"cDNA cloning, genomic structure determination and mutation screening","pmids":["15953485"],"confidence":"Medium","gaps":["Functional differences among isoforms not defined","No protein-level or activity comparison of isoforms"]},{"year":2010,"claim":"Demonstrated SRR is bifunctional, operating in both racemase and alpha,beta-eliminase modes, and linked extracellular D-serine to ASCT2 transport.","evidence":"SRR overexpression and RNAi in C6 glioma cells with D-serine/pyruvate measurement, [3H]D-serine uptake and immunoblot","pmids":["20091774"],"confidence":"Medium","gaps":["Single cell line and single lab","Physiological balance between the two enzymatic modes in vivo unresolved"]},{"year":2011,"claim":"Established SRR as the major source of forebrain D-serine through region-specific depletion in knockout mice.","evidence":"Srr-KO mice with HPLC amino acid quantification across brain regions and in vivo microdialysis","pmids":["21906644"],"confidence":"High","gaps":["Identity of the cerebellar D-serine biosynthetic pathway not determined","Downstream NMDA receptor consequences not directly measured here"]},{"year":2013,"claim":"Extended SRR's influence to forebrain D-aspartic acid levels, placing it upstream of D-aspartate via a D-serine-dependent route rather than altered catabolism.","evidence":"Srr-KO mice, HPLC quantification and DDO enzymatic activity assay","pmids":["23439386"],"confidence":"Medium","gaps":["The SRR→D-serine→D-aspartate pathway is not biochemically resolved","Single lab"]},{"year":2024,"claim":"Linked SRR activity to retinal neuroprotection and systemic glucose homeostasis using pharmacological inhibition in diabetic models.","evidence":"Competitive inhibitor L-ABH (oral and intravitreal) in db/db and diet-induced obesity mice with electroretinography, histological cell counts and glucose tolerance tests (preprint)","pmids":[],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Molecular mechanism linking SRR inhibition to glucose homeostasis not defined","Off-target effects of L-ABH not excluded"]},{"year":null,"claim":"How SRR's racemase versus eliminase activities are partitioned in vivo, what regulates the enzyme in mammalian neurons, and the mechanistic basis of its metabolic effects remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural or allosteric regulation data in the corpus","Cerebellar D-serine source unidentified","Mechanism connecting SRR to glucose homeostasis unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016853","term_label":"isomerase activity","supporting_discovery_ids":[0,2,3]},{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[2,9]}],"localization":[],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,4]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9GZT4","full_name":"Serine racemase","aliases":["D-serine ammonia-lyase","D-serine dehydratase","L-serine ammonia-lyase","L-serine dehydratase"],"length_aa":340,"mass_kda":36.6,"function":"Catalyzes the synthesis of D-serine from L-serine (PubMed:20106978, PubMed:23391306, PubMed:29277459). D-serine is a key coagonist with glutamate at NMDA receptors. Has dehydratase activity towards both L-serine and D-serine (By similarity)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q9GZT4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SRR","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SRR","total_profiled":1310},"omim":[{"mim_id":"616351","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SPEECH DELAY, AND DYSMORPHIC FACIES; NEDHSF","url":"https://www.omim.org/entry/616351"},{"mim_id":"606477","title":"SERINE RACEMASE; SRR","url":"https://www.omim.org/entry/606477"},{"mim_id":"604677","title":"CERAMIDE TRANSPORTER 1; CERT1","url":"https://www.omim.org/entry/604677"},{"mim_id":"604490","title":"SACSIN; SACS","url":"https://www.omim.org/entry/604490"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SRR"},"hgnc":{"alias_symbol":["ILV1","ISO1"],"prev_symbol":[]},"alphafold":{"accession":"Q9GZT4","domains":[{"cath_id":"3.40.50.1100","chopping":"10-56_157-324","consensus_level":"medium","plddt":97.904,"start":10,"end":324},{"cath_id":"3.40.50.1100","chopping":"57-151","consensus_level":"medium","plddt":92.3801,"start":57,"end":151}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZT4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZT4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZT4-F1-predicted_aligned_error_v6.png","plddt_mean":93.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SRR","jax_strain_url":"https://www.jax.org/strain/search?query=SRR"},"sequence":{"accession":"Q9GZT4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9GZT4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9GZT4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZT4"}},"corpus_meta":[{"pmid":"15953485","id":"PMC_15953485","title":"Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.","date":"2005","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15953485","citation_count":135,"is_preprint":false},{"pmid":"16549667","id":"PMC_16549667","title":"A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae.","date":"2006","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16549667","citation_count":98,"is_preprint":false},{"pmid":"17709412","id":"PMC_17709412","title":"The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells.","date":"2007","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/17709412","citation_count":93,"is_preprint":false},{"pmid":"26913720","id":"PMC_26913720","title":"MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.","date":"2016","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/26913720","citation_count":87,"is_preprint":false},{"pmid":"21906644","id":"PMC_21906644","title":"Levels of D-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice.","date":"2011","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/21906644","citation_count":84,"is_preprint":false},{"pmid":"20488193","id":"PMC_20488193","title":"The sacsin repeating region (SRR): a novel Hsp90-related supra-domain associated with neurodegeneration.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20488193","citation_count":51,"is_preprint":false},{"pmid":"1448083","id":"PMC_1448083","title":"A REB1-binding site is required for GCN4-independent ILV1 basal level transcription and can be functionally replaced by an ABF1-binding site.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1448083","citation_count":39,"is_preprint":false},{"pmid":"18438437","id":"PMC_18438437","title":"Isolation of wheat-rye 1RS recombinants that break the linkage between the stem rust resistance gene SrR and secalin.","date":"2008","source":"Genome","url":"https://pubmed.ncbi.nlm.nih.gov/18438437","citation_count":26,"is_preprint":false},{"pmid":"23439386","id":"PMC_23439386","title":"Decreased levels of free D-aspartic acid in the forebrain of serine racemase (Srr) knock-out mice.","date":"2013","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/23439386","citation_count":26,"is_preprint":false},{"pmid":"26007721","id":"PMC_26007721","title":"A Negative Index Metamaterial-Inspired UWB Antenna with an Integration of Complementary SRR and CLS Unit Cells for Microwave Imaging Sensor Applications.","date":"2015","source":"Sensors (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/26007721","citation_count":26,"is_preprint":false},{"pmid":"15060608","id":"PMC_15060608","title":"Resistance genes for rye stem rust (SrR) and barley powdery mildew (Mla) are located in syntenic regions on short arm of chromosome.","date":"2004","source":"Genome","url":"https://pubmed.ncbi.nlm.nih.gov/15060608","citation_count":22,"is_preprint":false},{"pmid":"20091774","id":"PMC_20091774","title":"D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO).","date":"2010","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/20091774","citation_count":20,"is_preprint":false},{"pmid":"9323359","id":"PMC_9323359","title":"Locus-specific suppression of ilv1 in Saccharomyces cerevisiae by deregulation of CHA1 transcription.","date":"1997","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/9323359","citation_count":16,"is_preprint":false},{"pmid":"35046895","id":"PMC_35046895","title":"qPCR Analysis Reveals Association of Differential Expression of SRR, NFKB1, and PDE4B Genes With Type 2 Diabetes Mellitus.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35046895","citation_count":16,"is_preprint":false},{"pmid":"11699952","id":"PMC_11699952","title":"Neurovirulence in mice of soluble receptor-resistant (srr) mutants of mouse hepatitis virus: intensive apoptosis caused by less virulent srr mutant.","date":"2001","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11699952","citation_count":16,"is_preprint":false},{"pmid":"3302681","id":"PMC_3302681","title":"Complementation of a threonine dehydratase-deficient Nicotiana plumbaginifolia mutant after Agrobacterium tumefaciens-mediated transfer of the Saccharomyces cerevisiae ILV1 gene.","date":"1987","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3302681","citation_count":15,"is_preprint":false},{"pmid":"32155456","id":"PMC_32155456","title":"Effect of SrR delivery in the biomarkers of bone regeneration during the in vitro degradation of HNT/GN coatings prepared by EPD.","date":"2020","source":"Colloids and surfaces. B, Biointerfaces","url":"https://pubmed.ncbi.nlm.nih.gov/32155456","citation_count":13,"is_preprint":false},{"pmid":"11706001","id":"PMC_11706001","title":"Neither Reb1p nor poly(dA*T) elements are responsible for the highly specific chromatin organization at the ILV1 promoter.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11706001","citation_count":12,"is_preprint":false},{"pmid":"28787945","id":"PMC_28787945","title":"A Miniaturized Antenna with Negative Index Metamaterial Based on Modified SRR and CLS Unit Cell for UWB Microwave Imaging Applications.","date":"2015","source":"Materials (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/28787945","citation_count":12,"is_preprint":false},{"pmid":"9613577","id":"PMC_9613577","title":"Datin, a yeast poly(dA:dT)-binding protein, behaves as an activator of the wild-type ILV1 promoter and interacts synergistically with Reb1p.","date":"1998","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/9613577","citation_count":11,"is_preprint":false},{"pmid":"19724605","id":"PMC_19724605","title":"A tunable multi-band metamaterial design using micro-split SRR structures.","date":"2009","source":"Optics express","url":"https://pubmed.ncbi.nlm.nih.gov/19724605","citation_count":8,"is_preprint":false},{"pmid":"24843648","id":"PMC_24843648","title":"Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population.","date":"2012","source":"Journal of diabetes investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24843648","citation_count":7,"is_preprint":false},{"pmid":"29363864","id":"PMC_29363864","title":"SRR intronic variation inhibits expression of its neighbouring SMG6 gene and protects against temporal lobe epilepsy.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29363864","citation_count":5,"is_preprint":false},{"pmid":"10052846","id":"PMC_10052846","title":"Anti-HIV activity and mechanism of action of macrocyclic diamide SRR-SB3.","date":"1998","source":"The Journal of pharmacy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10052846","citation_count":5,"is_preprint":false},{"pmid":"25603146","id":"PMC_25603146","title":"Structure of KRT4 binding domain of Srr-1 from Streptococcus agalactiae reveals a novel β-sheet complementation.","date":"2015","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/25603146","citation_count":4,"is_preprint":false},{"pmid":"35932430","id":"PMC_35932430","title":"Apricot kernels' extract and amygdalin alter bleomycin-induced Ty1 retrotransposition, mitotic gene conversion in the trp-5 locus and reverse point mutations in ilv1-92 allele in Saccharomyces cerevisiae.","date":"2022","source":"Archives of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/35932430","citation_count":2,"is_preprint":false},{"pmid":"15746898","id":"PMC_15746898","title":"Quantification of vitellogenin in several developmental stages of medaka (Oryzias latipes) S-rR strain.","date":"2004","source":"Environmental sciences : an international journal of environmental physiology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/15746898","citation_count":2,"is_preprint":false},{"pmid":"38390122","id":"PMC_38390122","title":"SRR inspired inversion symmetry-shaped left-handed metamaterial with a high effective medium ratio for ASR and WLAN applications.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38390122","citation_count":1,"is_preprint":false},{"pmid":"35009438","id":"PMC_35009438","title":"Application of a Single Cell Electric-SRR Metamaterial for Strain Evaluation.","date":"2021","source":"Materials (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35009438","citation_count":1,"is_preprint":false},{"pmid":"42095478","id":"PMC_42095478","title":"Tunable High-Performance Metamaterial Filters Based on Novel SRR Architectures.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/42095478","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.12.675721","title":"Mechanism of SARS-CoV-2 Nucleocapsid Protein Phosphorylation-induced Functional Switch","date":"2025-09-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.12.675721","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.25.25340959","title":"Impact of cell type specific variations and age in aortic distensibility","date":"2025-11-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.25.25340959","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.20.25340670","title":"Untargeted 1H NMR-based metabolomics and high-pressure liquid chromatography analysis reveal sexual dimorphism in the serum metabolic profiles of Parkinson’s disease patients harbouring rare genetic variants","date":"2025-11-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.20.25340670","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.30.25339159","title":"Untargeted  <sup>1</sup>  H NMR-based metabolomics reveal sex-based differences in blood metabolome profiles among patients with Parkinson’s disease, regardless of their idiopathic or genetic subtype","date":"2025-11-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.30.25339159","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.09.25325550","title":"Phase 2/3 open-label study on NVX-CoV-2601 (XBB.1.5) vaccine in previously COVID-19 mRNA vaccinated and vaccine-naive participants: a 6-month follow-up","date":"2025-04-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.09.25325550","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.23.24313965","title":"Biometry and volumetry in multi-centric fetal brain MRI: assessing the bias of super-resolution reconstruction","date":"2024-09-24","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.23.24313965","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.20.25334074","title":"Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trial","date":"2025-08-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.20.25334074","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.18.624080","title":"Pathogen threat proximity shapes host extracellular vesicle production in pre-infection response","date":"2024-11-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.18.624080","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.06.30.601441","title":"Inhibition of serine racemase prevents diabetic retinopathy","date":"2024-07-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.30.601441","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.06.28.601169","title":"Assessing data quality on fetal brain MRI reconstruction: a multi-site and multi-rater study⋆","date":"2024-07-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.28.601169","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.25.24316129","title":"Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: primary day-28 analysis of a phase 2/3 open-label study","date":"2024-11-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.25.24316129","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.02.24309854","title":"Association between social and environmental determinants of health with suicide-related death among veterans","date":"2024-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.02.24309854","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25469,"output_tokens":2820,"usd":0.059353,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10102,"output_tokens":2977,"usd":0.062468,"stage2_stop_reason":"end_turn"},"total_usd":0.121821,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"SRR (serine racemase) is the major enzyme responsible for D-serine production in the mouse forebrain (frontal cortex, hippocampus, striatum), as demonstrated by significantly reduced D-serine levels in Srr-KO mice in these regions; cerebellar D-serine was unaffected, suggesting alternative biosynthetic pathways exist there. In vivo microdialysis confirmed reduced extracellular hippocampal D-serine in Srr-KO mice.\",\n      \"method\": \"Srr knockout mice, HPLC amino acid quantification across brain regions and peripheral organs, in vivo microdialysis\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined biochemical phenotype across multiple brain regions and peripheral organs, replicated with two orthogonal methods (tissue quantification and in vivo microdialysis)\",\n      \"pmids\": [\"21906644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SRR knockout mice show significantly reduced D-aspartic acid levels in forebrain regions (frontal cortex, hippocampus, striatum) but not cerebellum, suggesting SRR and/or D-serine is involved in D-aspartic acid production in the forebrain. D-aspartate oxidase (DDO) activity was unchanged in Srr-KO forebrains, ruling out altered catabolism as an explanation.\",\n      \"method\": \"Srr knockout mice, HPLC amino acid quantification, DDO enzymatic activity assay\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean KO with defined biochemical phenotype, single lab, indirect mechanism (SRR→D-serine→D-aspartate pathway not fully resolved)\",\n      \"pmids\": [\"23439386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In C6 glioma cells expressing SRR but lacking DAO activity, SRR overexpression increased D-serine and pyruvate levels and decreased ASCT2 mRNA and [(3)H]D-serine uptake, demonstrating SRR operates in both racemase mode (producing D-serine) and alpha,beta-eliminase mode (converting D-serine to pyruvate). ASCT2-mediated transport contributes to D-serine homeostasis in DAO-deficient cells.\",\n      \"method\": \"SRR overexpression and RNAi knockdown in C6 glioma cells, D-serine/pyruvate measurement, [(3)H]D-serine uptake assay, immunoblot\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function and loss-of-function with multiple biochemical readouts, single lab\",\n      \"pmids\": [\"20091774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Human brain SRR transcripts consist of four mRNA isoforms with one major species, arising from alternative use of various 5' end exons, as determined by complete cDNA and genomic structure analysis. SRR encodes an enzyme catalyzing formation of D-serine from L-serine.\",\n      \"method\": \"cDNA cloning, genomic structure determination, mutation screening\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cDNA/genomic structural characterization with identification of isoforms, single lab\",\n      \"pmids\": [\"15953485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Inhibition of SRR by oral gavage of L-aspartic acid β-hydroxamate (L-ABH), a competitive inhibitor of SRR, mitigated photoreceptor dysfunction, loss of retinal ganglion cells, and loss of retinal endothelial cells and pericytes in db/db diabetic mice. Intravitreal L-ABH also mitigated glutamate-induced neurotoxicity in the retina. Systemic L-ABH maintained euglycemia and improved glucose tolerance in diabetic and diet-induced obesity mice, establishing a neuroprotective and metabolic role for SRR inhibition in diabetic retinopathy.\",\n      \"method\": \"In vivo pharmacological inhibition (competitive inhibitor L-ABH) in db/db mice, intravitreal injection, electroretinography, histological cell counts, glucose tolerance tests\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological loss-of-function with multiple cellular and metabolic readouts in disease model, single lab, preprint not peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The ILV1 gene of S. cerevisiae (encoding threonine dehydratase, the yeast ortholog of SRR/ILV1) requires a REB1-binding site (ILV1BAS) for GCN4-independent basal-level transcription. Gel retardation assays showed REB1 specifically binds this element. An ABF1-binding site can functionally substitute for the REB1 site, suggesting related transcriptional activation functions for these proteins at ILV1.\",\n      \"method\": \"ILV1 promoter deletion analysis, gel retardation assay (EMSA), reporter gene assays, point mutation analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro binding assay (EMSA) plus in vivo promoter deletion and point mutation analysis, single lab; pertains to yeast ILV1 ortholog regulation\",\n      \"pmids\": [\"1448083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Dat1p (datin), the yeast poly(dA:dT)-binding protein, specifically binds the ILV1 poly(dA:dT) promoter element in vitro and functions as a trans-activating factor for ILV1 expression. The REB1-binding site and the poly(dA:dT) element act synergistically in a distance-dependent manner to control ILV1 basal-level expression, and this synergy depends on the DAT1 structural gene.\",\n      \"method\": \"In vitro binding assay (gel retardation/EMSA), in vivo promoter deletion analysis, DAT1 gene deletion epistasis, reporter gene assays\",\n      \"journal\": \"Molecular & general genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding plus in vivo genetic epistasis and reporter assays, single lab; pertains to yeast ILV1 ortholog\",\n      \"pmids\": [\"9613577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Chromatin analysis of the yeast ILV1 locus revealed highly positioned nucleosomes with a hypersensitive site in the promoter region containing all known regulatory elements. However, replacing or deleting the poly(dA:dT) elements or the REB1-binding site drastically reduced ILV1 basal transcription without detectably altering chromatin structure at the promoter, demonstrating the chromatin organization is independent of these regulatory elements and is most likely dictated directly by DNA sequence.\",\n      \"method\": \"Chromatin structure analysis (nucleosome mapping), promoter deletion/substitution analysis, in vivo transcription assays\",\n      \"journal\": \"Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chromatin structure mapping combined with mutational analysis; single lab; yeast ILV1 ortholog\",\n      \"pmids\": [\"11706001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Phenotypic suppression of yeast ilv1 (threonine dehydratase deficiency) can occur via inducer-mediated or constitutive transcriptional activation of CHA1, a second serine/threonine deaminase. Genetic analysis identified SIL4 (allelic to HOM3) as a dominant suppressor that increases the threonine pool 15-20-fold to induce CHA1 transcription; SIL3 and sil2 (both alleles of CHA4) constitutively activate CHA1 transcription as dominant and recessive suppressors, respectively.\",\n      \"method\": \"Suppressor screen, genetic epistasis analysis, CHA1-lacZ reporter assay, metabolite pool measurement\",\n      \"journal\": \"Molecular & general genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic suppressor analysis with epistasis and reporter gene confirmation, single lab; yeast ILV1 ortholog\",\n      \"pmids\": [\"9323359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"The S. cerevisiae ILV1 gene product (threonine dehydratase, EC 4.2.1.16) functionally complements a threonine dehydratase-deficient Nicotiana plumbaginifolia plant mutant after Agrobacterium-mediated gene transfer, confirming that ILV1 encodes a functional threonine dehydratase enzyme conserved in activity across kingdoms.\",\n      \"method\": \"Heterologous complementation via Agrobacterium-mediated gene transfer, enzymatic activity assay for threonine dehydratase in transformed plant lines, selection on isoleucine-free medium\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional complementation assay combined with direct enzymatic activity measurement, confirming catalytic function of ILV1 gene product\",\n      \"pmids\": [\"3302681\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SRR (serine racemase) is a pyridoxal-5'-phosphate-dependent enzyme that catalyzes the racemization of L-serine to D-serine (and can also operate in alpha,beta-eliminase mode producing pyruvate), making it the primary source of D-serine — an endogenous NMDA receptor co-agonist — in the mammalian forebrain; SRR also appears to influence D-aspartic acid levels in the forebrain and plays roles in retinal neuroprotection and glucose homeostasis, while its yeast ortholog (ILV1/threonine dehydratase) is regulated at the transcriptional level by REB1 and Dat1p binding to the promoter in a synergistic, distance-dependent manner.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SRR (serine racemase) is the principal enzyme generating D-serine in the mammalian forebrain, where D-serine acts as an endogenous co-agonist of the NMDA receptor; genetic ablation of Srr in mice selectively depletes D-serine in frontal cortex, hippocampus, and striatum while sparing the cerebellum, which retains alternative biosynthetic routes [#0]. Biochemically the enzyme is bifunctional: in cells expressing SRR it both produces D-serine in racemase mode and converts D-serine to pyruvate in an alpha,beta-eliminase mode, with extracellular D-serine homeostasis further shaped by ASCT2-mediated transport [#2]. SRR activity also influences forebrain D-aspartic acid levels through a mechanism downstream of D-serine rather than altered D-aspartate catabolism [#1]. Pharmacological inhibition of SRR with the competitive inhibitor L-aspartic acid \\u03b2-hydroxamate is neuroprotective in the diabetic retina and improves glucose tolerance, implicating the enzyme in retinal disease and metabolic homeostasis [#4]. The gene is expressed as multiple mRNA isoforms arising from alternative 5' exon usage [#3]. The yeast ortholog ILV1 encodes a functional threonine dehydratase whose conserved catalytic activity has been demonstrated by cross-kingdom complementation [#9], and whose basal transcription is governed by REB1- and Dat1p-binding promoter elements acting synergistically in a distance-dependent manner [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Established that the ancestral/ortholog gene product is a catalytically active enzyme, anchoring the protein's biochemical identity before its mammalian racemase role was known.\",\n      \"evidence\": \"Agrobacterium-mediated transfer of yeast ILV1 complementing a threonine dehydratase-deficient plant mutant with direct enzyme activity measurement\",\n      \"pmids\": [\"3302681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address racemase activity or D-serine production\", \"Yeast/plant system, not mammalian SRR\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Defined how basal transcription of the yeast ortholog is controlled, identifying a REB1-binding promoter element required for GCN4-independent expression.\",\n      \"evidence\": \"ILV1 promoter deletion/point-mutation analysis plus EMSA showing specific REB1 binding, with ABF1 site substitution\",\n      \"pmids\": [\"1448083\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Yeast-specific transcriptional regulation; mammalian SRR promoter not addressed\", \"Mechanism of REB1/ABF1 functional equivalence unresolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Mapped genetic suppressors that bypass loss of the yeast deaminase, illuminating metabolic compensation through CHA1 activation.\",\n      \"evidence\": \"Suppressor screen, epistasis, CHA1-lacZ reporter and metabolite pool measurement in yeast ilv1 mutants\",\n      \"pmids\": [\"9323359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pertains to yeast amino acid metabolism, not mammalian D-serine function\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed that a second promoter element bound by Dat1p cooperates with the REB1 site to drive basal expression, defining a synergistic distance-dependent regulatory architecture for the ortholog.\",\n      \"evidence\": \"EMSA binding, promoter deletion, DAT1 deletion epistasis and reporter assays in yeast\",\n      \"pmids\": [\"9613577\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Yeast-specific; relevance to mammalian SRR regulation unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Determined that the ordered chromatin structure at the ortholog promoter is sequence-dictated and independent of the regulatory elements driving transcription.\",\n      \"evidence\": \"Nucleosome mapping with promoter deletion/substitution and in vivo transcription assays in yeast\",\n      \"pmids\": [\"11706001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Yeast-specific chromatin context\", \"Does not connect to mammalian enzyme function\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Characterized the human gene structure, revealing four mRNA isoforms from alternative 5' exon usage in human brain.\",\n      \"evidence\": \"cDNA cloning, genomic structure determination and mutation screening\",\n      \"pmids\": [\"15953485\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional differences among isoforms not defined\", \"No protein-level or activity comparison of isoforms\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated SRR is bifunctional, operating in both racemase and alpha,beta-eliminase modes, and linked extracellular D-serine to ASCT2 transport.\",\n      \"evidence\": \"SRR overexpression and RNAi in C6 glioma cells with D-serine/pyruvate measurement, [3H]D-serine uptake and immunoblot\",\n      \"pmids\": [\"20091774\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line and single lab\", \"Physiological balance between the two enzymatic modes in vivo unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established SRR as the major source of forebrain D-serine through region-specific depletion in knockout mice.\",\n      \"evidence\": \"Srr-KO mice with HPLC amino acid quantification across brain regions and in vivo microdialysis\",\n      \"pmids\": [\"21906644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the cerebellar D-serine biosynthetic pathway not determined\", \"Downstream NMDA receptor consequences not directly measured here\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended SRR's influence to forebrain D-aspartic acid levels, placing it upstream of D-aspartate via a D-serine-dependent route rather than altered catabolism.\",\n      \"evidence\": \"Srr-KO mice, HPLC quantification and DDO enzymatic activity assay\",\n      \"pmids\": [\"23439386\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The SRR\\u2192D-serine\\u2192D-aspartate pathway is not biochemically resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked SRR activity to retinal neuroprotection and systemic glucose homeostasis using pharmacological inhibition in diabetic models.\",\n      \"evidence\": \"Competitive inhibitor L-ABH (oral and intravitreal) in db/db and diet-induced obesity mice with electroretinography, histological cell counts and glucose tolerance tests (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Molecular mechanism linking SRR inhibition to glucose homeostasis not defined\", \"Off-target effects of L-ABH not excluded\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SRR's racemase versus eliminase activities are partitioned in vivo, what regulates the enzyme in mammalian neurons, and the mechanistic basis of its metabolic effects remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural or allosteric regulation data in the corpus\", \"Cerebellar D-serine source unidentified\", \"Mechanism connecting SRR to glucose homeostasis unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [2, 9]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}